1. ScholarBank@NUS

Bin Tean Teh

rp04837

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Bin Tean Teh
Variants
Teh, B.T.
Teh, B.-T.
Teh Bin Tean
Teh, Bin Tean
 
Main Affiliation
 
Faculty
 
Email
gmstbt@nus.edu.sg
 
Other emails
 

Publications

Refined By:
File Format:  Adobe PDF
Subject:  controlled study

Results 1-17 of 17 (Search time: 0.026 seconds).

Issue DateTitleAuthor(s)
120103D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinomaRen, Y.-F; Gao, Y.-H; Cao, X.-P; Ye, W.-J; Teh, B.S 
220143D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinomaRen, Y.F; Zhao, Q.C; Liu, H; Huang, Y.J; Wang, Z.Y; Cao, X.P; Teh, B.S ; Wen, B.X
320133D-image-guided high-dose-rate intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinomaRen, Y.-F; Cao, X.-P; Xu, J; Ye, W.-J; Gao, Y.-H; Teh, B.S ; Wen, B.-X
42016Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneityOoi, W.F; Xing, M; Xu, C ; Yao, X; Ramlee, M.K; Lim, M.C ; Cao, F ; Lim, K ; Babu, D ; Poon, L.-F ; Lin Suling, J; Qamra, A ; Irwanto, A; Qu Zhengzhong, J; Nandi, T; Lee-Lim, A.P; Chan, Y.S; Tay, S.T ; Lee, M.H ; Davies, J.O.J; Wong, W.K; Soo, K.C ; Chan, W.H ; Ong, H.S ; Chow, P ; Wong, C.Y ; Rha, S.Y; Liu, J; Hillmer, A.M; Hughes, J.R; Rozen, S ; Teh, B.T ; Fullwood, M.J ; Li, S ; Tan, P 
52015Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppressionWu, M; Si, S; Li, Y; Schoen, S; Xiao, G.-Q; Li, X; Teh, B.T ; Wu, G; Chen, J
62018Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancerTang Y.C. ; Ho S.-C. ; Tan E. ; Ng A.W.T. ; McPherson J.R. ; Goh G.Y.L.; Teh B.T. ; Bard F. ; Rozen S.G. 
72004Gene Expression Profiling of Early- and Late-Relapse Nonseminomatous Germ Cell Tumor and Primitive Neuroectodermal Tumor of the TestisSugimura, J; Foster, R.S; Cummings, O.W; Kort, E.J; Takahashi, M; Lavery, T.T; Furge, K.A; Einhorn, L.H; Teh, B.T 
82017Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: Model for the hyperparathyroidism-jaw tumour syndromeWalls, G.V; Stevenson, M; Lines, K.E; Newey, P.J; Reed, A.A.C; Bowl, M.R; Jeyabalan, J; Harding, B; Bradley, K.J; Manek, S; Chen, J; Wang, P; Williams, B.O; Teh, B.T ; Thakker, R.V
92017Negative regulation of EGFR signalling by the human folliculin tumour suppressor proteinLaviolette L.A.; Mermoud J.; Calvo I.A.; Olson N.; Boukhali M.; Steinlein O.K.; Roider E.; Sattler E.C.; Huang D. ; Teh B.T. ; Motamedi M.; Haas W.; Iliopoulos O.
102014Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling GenesMalouf, G.G; Su, X; Yao, H; Gao, J; Xiong, L; He, Q; Compérat, E; Couturier, J; Molinié, V; Escudier, B; Camparo, P; Doss, D.J; Thompson, E.J; Khayat, D; Wood, C.G; Yu, W ; Teh, B.T ; Weinstein, J; Tannir, N.M
112012The effect of Aurora kinases on cell proliferation, cell cycle regulation and metastasis in renal cell carcinomaLi, Y; Zhou, W; Wei, L; Jin, J; Tang, K; Li, C; Teh, B.T ; Chen, X
122018The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysisHuang, Y; Chen, W; Haque, W; Verma, V; Xing, Y; Teh, B.S ; Brian Butler, E
132013The investigational aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivoZhou, N; Singh, K; Mir, M.C; Parker, Y; Lindner, D; Dreicer, R; Ecsedy, J.A; Zhang, Z; Teh, B.T ; Almasan, A; Hansel, D.E
142005Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinomaMorris, M.R; Gentle, D; Abdulrahman, M; Maina, E.N; Gupta, K; Banks, R.E; Wiesener, M.S; Kishida, T; Yao, M; Teh, B ; Lauf, F; Maher, E.R
152007Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implicationsYao, X; Qian, C.-N; Zhang, Z.-F; Tan, M.-H ; Kort, E.J; Yang, X.J; Resau, J.H; Teh, B.T 
162017VHL deficiency drives enhancer activation of oncogenes in clear cell renal cell carcinomaYao, X; Tan, J; Lim, K.J ; Koh, J; Ooi, W.F; Li, Z; Huang, D; Xing, M; Chan, Y.S; Qu, J.Z; Tay, S.T ; Wijaya, G; Lam, Y.N; Hong, J.H ; Lee-Lim, A.P; Guan, P; Ng, M.S.W; He, C.Z; Lin, J.S; Nandi, T; Qamra, A ; Xu, C ; Myint, S.S; Davies, J.O.J; Goh, J.Y; Loh, G; Tan, B.C; Rozen, S.G ; Yu, Q ; Tan, I.B.H ; Cheng, C.W.S ; Li, S ; Chang, K.T.E ; Tan, P.H; Silver, D.L ; Lezhava, A; Steger, G; Hughes, J.R; Teh, B.T ; Tan, P 
172007VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snailEvans, A.J; Russell, R.C; Roche, O; Burry, T.N; Fish, J.E; Chow, V.W.K; Kim, W.Y; Saravanan, A; Maynard, M.A; Gervais, M.L; Sufan, R.I; Roberts, A.M; Wilson, L.A; Betten, M; Vandewalle, C; Berx, G; Marsden, P.A; Irwin, M.S; Teh, B.T ; Jewett, M.A.S; Ohh, M